WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma

Carcinogenesis

Volumn 36, Issue 5, 2015, Pages 598-606

  Long, Apple ^a   Giroux, Véronique ^a   Whelan, Kelly A ^a   Hamilton, Kathryn E ^a   Tétreault, Marie Pier ^a   Tanaka, Koji ^a   Lee, Ju Seog ^b   Klein Szanto, Andres J ^c   Nakagawa, Hiroshi ^a   Rustgi, Anil K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WNT10A PROTEIN; MESSENGER RNA; WNT PROTEIN; WNT10A PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; KERATINOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSFORMED CELL; TUMOR INVASION; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ESOPHAGUS; ESOPHAGUS TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MORTALITY; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; WNT PROTEINS;

EID: 84929177445     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv025     Document Type: Article

References (53)

1. Altekruse, S.F. et al. (eds) SEER Cancer Statistics Review, 1975-2011. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2011/.
2. Enzinger, P.C. et al. (2003) Esophageal cancer. N. Engl. J. Med., 349, 2241-2252.
3. Lu, F. et al. (2003) An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res., 63, 7056-7061.
4. Song, Y. et al. (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature, 509, 91-95.
5. Stairs, D.B. et al. (2011) Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell, 19, 470-483.
6. Okawa, T. et al. (2007) The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev., 21, 2788-2803.
7. Kalabis, J. et al. (2012) Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture. Nat. Protoc., 7, 235-246.
8. Michaylira, C.Z. et al. (2010) Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Res., 70, 5281-5292.
9. Wong, G.S. et al. (2013) Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment. Oncogenesis, 2, e59.
10. Wong, G.S. et al. (2013) Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology, 144, 294-297.
11. Clevers, H. et al. (2012) Wnt/ß-catenin signaling and disease. Cell, 149, 1192-1205.
12. MacDonald, B.T. et al. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17, 9-26.
13. Willert, K. et al. (2012) Wnt proteins. Cold Spring Harb. Perspect. Biol., 4, a007864.
14. Polakis, P. (2012) Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol., 4, a008052.
15. Staal, F.J. et al. (2008) WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol., 8, 581-593.
16. Wang, J. et al. (1996) Murine Wnt10a and Wnt10b: cloning and expression in developing limbs, face and skin of embryos and in adults. Oncogene, 13, 1537-1544.
17. Kirikoshi, H. et al. (2001) WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells. Biochem. Biophys. Res. Commun., 283, 798-805.
18. Adaimy, L. et al. (2007) Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. Am. J. Hum. Genet., 81, 821-828.
19. Bohring, A. et al. (2009) WNT10A mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes. Am. J. Hum. Genet., 85, 97-105.
20. Nawaz, S. et al. (2009) WNT10A missense mutation associated with a complete odonto-onycho-dermal dysplasia syndrome. Eur. J. Hum. Genet., 17, 1600-1605.
21. Cluzeau, C. et al. (2011) Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. Hum. Mutat., 32, 70-72.
22. Reddy, S. et al. (2001) Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis. Mech. Dev., 107,69-82.
23. Itin, P.H. (2014) Etiology and pathogenesis of ectodermal dysplasias. Am. J. Med. Genet. A, 164A, 2472-2477.
24. Visel, A. et al. (2004) GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res., 32, D552-D556.
25. Hsu, R.J. et al. (2012) WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/ß-catenin pathway. PLoS One, 7, e47649.
26. Li, J. et al. (2001) Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem., 276, 18579-18590.
27. Kirikoshi, H. et al. (2001) Expression of WNT10A in human cancer. Int. J. Oncol., 19, 997-1001.
28. Kirikoshi, H. et al. (2001) Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int. J. Oncol., 19, 533-536.
29. Kurasawa, Y. et al. (2012) Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells. Oncogene, 31, 1963-1974.
30. Ordway, J.M. et al. (2006) Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis, 27, 2409-2423.
31. Krämer, A. et al. (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics, 30, 523-530.
32. Harada, H. et al. (2003) Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol. Cancer Res., 1, 729-738.
33. Nishihira, T. et al. (1993) Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol., 119, 441-449.
34. Nakagawa, H. et al. (1995) Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer, 76, 541-549.
35. Najdi, R. et al. (2012) A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation, 84, 203-213.
36. Tang, X.H. et al. (2004) Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Cancer Res., 10(1 Pt 1), 301-313.
37. Natsuizaka, M. et al. (2014) IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. Am. J. Cancer Res., 4, 29-41.
38. Schneider, C.A. et al. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods, 9, 671-675.
39. Wielenga, V.J. et al. (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol., 154, 515-523.
40. Zhao, J.S. et al. (2011) Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS One, 6.
41. Al-Hajj, M. et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A., 100, 3983-3988.
42. Mani, S.A. et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715.
43. Narita, T. et al. (2005) Wnt10a is involved in AER formation during chick limb development. Dev. Dyn., 233, 282-287.
44. Gao, N. et al. (2009) Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev. Cell, 16, 588-599.
45. Que, J. et al. (2007) Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development, 134, 2521-2531.
46. Okubo, T. et al. (2006) Sox2 is required for development of taste bud sensory cells. Genes Dev., 20, 2654-2659.
47. Bass, A.J. et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet., 41, 1238-1242.
48. Ji, H. et al. (2011) Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations. Proteomics, 11, 4029-4039.
49. Korinek, V. et al. (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet., 19, 379-383.
50. Reya, T. et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
51. Wong, G.S. et al. (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br. J. Cancer, 108, 755-761.
52. Malanchi, I. et al. (2012) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature, 481, 85-89.
53. Holland, J.D. et al. (2013) Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol., 25, 254-264.